SL
VRCA icon

Salomon & Ludwin’s Verrica Pharmaceuticals VRCA Stock Holding History

Salomon & Ludwin’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.72K Hold
290
– – ﹤0.01% 1979
2026
Q1 		$1.59K Hold
290
– – ﹤0.01% 1965
2025
Q4 		$2.57K Hold
290
– – ﹤0.01% 1958
2025
Q3 		$1.35K Hold
290
– – ﹤0.01% 2024
2025
Q2 		$1.88K Hold
290
– – ﹤0.01% 673
2025
Q1 		$1.28K Hold
290
– – ﹤0.01% 624
2024
Q4 		$2.03K Hold
290
– – ﹤0.01% 594
2024
Q3 		$4.21K Hold
290
– – ﹤0.01% 542
2024
Q2 		$21.1K Hold
290
– – ﹤0.01% 358
2024
Q1 		$17.2K Hold
290
– – ﹤0.01% 492
2023
Q4 		$11.3K Hold
290
– – ﹤0.01% 478
2023
Q3 		$11.3K Buy
+290
New +$14.7K ﹤0.01% 477

Other funds holding VRCA

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $149M AUM 39.81% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Salomon & Ludwin's VRCA Position: Q2 2026 in Review

Salomon & Ludwin held its Verrica Pharmaceuticals (VRCA) position steady in Q2 2026 at 290 shares worth $1.72K. The position accounts for ﹤0.01% of the portfolio, ranked #1979.

Salomon & Ludwin first reported a position in VRCA in Q3 2023 and has held it in 12 quarters since. The position peaked at $21.1K in Q2 2024. 43 funds tracked by Wall St. Rank hold VRCA as of Q2 2026.

  • Salomon & Ludwin held 290 shares of Verrica Pharmaceuticals worth $1.72K as of Q2 2026.
  • Salomon & Ludwin left its Verrica Pharmaceuticals share count unchanged in Q2 2026.
  • Verrica Pharmaceuticals made up ﹤0.01% of Salomon & Ludwin's portfolio in Q2 2026, its #1979 holding.
  • Salomon & Ludwin first reported a position in Verrica Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
  • Salomon & Ludwin's Verrica Pharmaceuticals position peaked at $21.1K in Q2 2024.
  • 43 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.